×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan
Yahoo Finance
SEATTLE, WA / ACCESSWIRE / March 4, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will...
1 month ago
Why Is Aptevo Therapeutics (APVO) Stock Down 56% Today?
InvestorPlace
Aptevo Therapeutics stock is falling on Thursday after the company priced a public offering for 3.4 million shares of APVO.
3 weeks ago
Aptevo Therapeutics Stockholders Approve Reverse Split - TipRanks.com
Tipranks
Aptevo Therapeutics Inc (APVO) has released an update to notify the public and investors about the submission of matters to a vote of...
2 months ago
Aptevo Therapeutics sets terms for $4.6 million public offering
Investing.com
SEATTLE - Aptevo Therapeutics Inc . (NASDAQ:APVO), a biotechnology firm engaged in developing cancer treatments, has announced the pricing...
3 weeks ago
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
Yahoo Finance
SEATTLE, WA / ACCESSWIRE / April 15, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on...
2 weeks ago
Aptevo Therapeutics slumps after discounted equity raise (NASDAQ:APVO)
Seeking Alpha
Aptevo Therapeutics stock falls as company prices public offering at $1.35 per share, with common warrants also at $1.35 per share.
3 weeks ago
Is Aptevo Therapeutics Inc (APVO) Stock a Smart Investment Thursday?
InvestorsObserver
Aptevo Therapeutics Inc (APVO) stock has fallen -95.22% over the last 12 months, and the average rating from Wall Street analysts is a...
1 month ago
Aptevo Therapeutics enacts reverse stock split to meet Nasdaq requirements
Investing.com
(NASDAQ:APVO), a clinical-stage biotech company, announced today a reverse stock split of its common stock at a ratio of 1-for-44, to be...
1 month ago
Why Is Aptevo Therapeutics (APVO) Stock Down 33% Today?
InvestorPlace
Aptevo Therapeutics (APVO) stock is sliding lower on Wednesday after the biotechnology company announced a public share offering.
8 months ago
Aptevo Therapeutics prices 3.4M shares at $1.35 in public offering - TipRanks.com
Tipranks
Aptevo Therapeutics announced the pricing of a public offering of 3400000 shares of its common stock or pre-funded warrants in lieu thereof and warrants to...
3 weeks ago